Yu Fan Aeglea Bio Therapeutics, Inc. Transaction History

Yu Fan

  • $1.03 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$20.99 - $27.66 $15.5 Million - $20.4 Million
737,000 New
737,000 $20.4 Million
Q3 2023

Nov 14, 2023
SELL
$0.43 - $14.94 $39,324 - $1.37 Million
-91,452 Reduced 81.62%
20,592 $252,000
Q4 2020

Feb 16, 2021
BUY
$7.02 - $9.83 $786,548 - $1.1 Million
112,044 New
112,044 $882,000

Others Institutions Holding AGLE

# of Institutions
1
Shares Held
241K
Call Options Held
0
Put Options Held
0
View Full List

About Aeglea BioTherapeutics, Inc.

AGLE Quotes by TradingView
  • Ticker AGLE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,172,500
  • Market Cap $1.69B
  • Description
  • Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...
More about AGLE
Track This Portfolio

Track Yu Fan Portfolio

Follow Yu Fan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yu Fan, based on Form 13F filings with the SEC.

News

Stay updated on Yu Fan with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email